Education for clinicians and reviewers on the new OASIS-E items for pain and their intent — as well as the included time frames and the recommended method of obtaining an accurate response — is vital ahead of implementation on Jan. 1.
Agencies should educate staff now on the significance of the addition of A1110 (Language) to the OASIS-E assessment come Jan. 1, as details could improve care plan compliance and lead to better outcomes.
Come April 2023, coders may be able to capture more data on social determinants of health, including problems related to health literacy.
CMS provides easier-to-understand verbiage, the addition of WOCN guidance, new item rationale and definition boxes in its draft OASIS-E Guidance Manual that can help clinicians answer tricky wound questions.
Find time to train clinicians on the new and revised OASIS-E social determinants of health (SDoH) — including health literacy, transportation, race and ethnicity — and your agency will benefit from better quality outcomes.
Do not assign E78.5 (Hyperlipidemia, unspecified) for a diagnosis of unspecified hyperlipidemia and hypercholesterolemia as the hypercholesterolemia identifies the specific blood lipid elevated, the Coding Clinic notes in its Q2 2022 guidance update, released June 3.
Any assistance or transportation required to get medications into the home should not be taken into consideration when answering OASIS items M2020 and M2030, CMS clarified in the quarterly Q&As, released April 19.
Use occupational therapists more often to evaluate patients’ environments, and you’ll reduce the number of visits that need to be completed and improve the patients’ outcomes.
When OASIS-E goes into effect on Jan. 1, 2023, agencies will be required to report when and how medication reconciliation occurs when the patient leaves the agency.
Recent CMS guidance on how to answer M2020 (Management of oral medications) and M2030 (Management of injectable medications) represents a shift from previous guidance.


User Name: